USPTO serial 74728120
GENULOC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 10, 1998
- Examiner
- WARD, JOYCE A.
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with GENULOC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
D-47906 Kempen, DE
D-47906 Kempen, DE
D-47906 Kempen, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Raymond R. Ferrera,
ALLYN TAYLOR DLA PIPER US LLP2000 UNIVERSITY AVEEAST PALO ALTO, CA 94303-2215UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | orthopedic aids, namely, support bandages, insoles, support stockings, and knee orthotics | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 13, 2008 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Aug 8, 2007 | CFIT | CASE FILE IN TICRS | — |
| Sep 15, 2006 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 21, 2005 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 8, 2003 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Oct 3, 2003 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Jun 3, 2003 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 10, 1998 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 23, 1998 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Jan 23, 1998 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Aug 26, 1997 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 3, 1997 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 2, 1997 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 20, 1997 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 5, 1997 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 2, 1996 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 1996 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 25, 1996 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 5, 1996 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 29, 1996 | DOCK | ASSIGNED TO EXAMINER | — |